What is the most recent earnings date for KALA stock?
KALA BIO INC (KALA) last reported earnings on 11/19/2025.
KALA BIO INC (KALA) Earnings History & Surprises
NASDAQ:KALA • US4831192020
Current stock price
0.1757 USD
-0.02 (-12.15%)
At close:
0.174 USD
0 (-0.97%)
After Hours:
KALA Earnings overview
Past quarterly earnings results for KALA BIO INC (KALA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.47
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 19, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.86
- EPS Surprise
- 41.67%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.86 | -1.47 | 41.67% | 55.44% | - | - | ||
| Q2 2025 | -1.71 | -1.74 | 1.58% | 45.89% | - | - | ||
| Q1 2025 | -1.41 | -2.07 | 31.90% | 66.35% | - | - | ||
| Q4 2024 | -1.74 | -2.33 | 25.18% | 45.28% | - | - | ||
| Q3 2024 | -1.93 | -2.48 | 22.13% | 43.40% | - | - | ||
| Q2 2024 | -3.16 | -4.49 | 29.67% | 27.52% | - | - | ||
| Q1 2024 | -4.19 | -2.95 | -42.14% | 40.06% | - | - | ||
| Q4 2023 | -3.18 | -3.69 | 13.88% | 60.10% | - | - | ||
| Q3 2023 | -3.41 | -2.20 | -55.16% | -117.71% | 849.997K | -100.00% | -100.00% | |
| Q2 2023 | -4.36 | -3.25 | -34.14% | 77.05% | - | -100.00% | ||
| Q1 2023 | -6.99 | -4.52 | -54.76% | 68.93% | - | -100.00% | ||
| Q4 2022 | -7.97 | -7.06 | -12.92% | 76.56% | - | -100.00% | ||
| Q3 2022 | 19.25 | 17.17 | 12.11% | 189.53% | 420K | 42.5M | -99.01% | -86.32% |
| Q2 2022 | -19.00 | -20.91 | 9.13% | 33.33% | 2.1M | 2.062M | 1.84% | -31.15% |
| Q1 2022 | -22.50 | -17.24 | -30.53% | 8.16% | 1.37M | 3.129M | -56.22% | -58.10% |
| Q4 2021 | -34.00 | -20.27 | -67.71% | -23.64% | 1.86M | 3.475M | -46.47% | -16.96% |
| Q3 2021 | -21.50 | -21.93 | 1.96% | 14.00% | 3.07M | 5.261M | -41.65% | 38.29% |
| Q2 2021 | -28.50 | -22.44 | -27.01% | -35.71% | 3.05M | 5.355M | -43.04% | 267.47% |
| Q1 2021 | -24.50 | -34.90 | 29.80% | 9.26% | 3.27M | 4.306M | -24.06% | 205.61% |
| Q4 2020 | -27.50 | -23.37 | -17.65% | - | 2.24M | 2.436M | -8.05% | - |
| Q3 2020 | -25.00 | -22.61 | -10.57% | - | 2.22M | 2.048M | 8.40% | - |
| Q2 2020 | -21.00 | -21.06 | 0.27% | - | 830K | 748.537K | 10.88% | - |
| Q1 2020 | -27.00 | -26.11 | -3.40% | - | 1.07M | 2.722M | -60.69% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
25.08%
Max EPS beat (4)
41.67%
Min EPS beat (4)
1.58%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, KALA has consistently beaten EPS estimates in all releases
In the last 4 quarters, KALA has beaten the EPS estimates by 25.1% on average.
Related analysis
KALA BIO INC / KALA Earnings FAQ
Did KALA BIO INC (KALA) beat earnings estimates last quarter?
KALA BIO INC (KALA) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does KALA BIO INC (KALA) beat earnings estimates?
In the last 4 quarters, KALA BIO INC (KALA) has beaten EPS estimates in 4 out of 4 releases.